scioAKI

About Sciomics

Sciomics is a Heidelberg-based proteomics service and product company leveraging a proprietary antibody microarray platform for high-content protein analysis. The company operates a dual model, offering fee-for-service profiling to external researchers while also developing its own internal pipeline of diagnostic biomarker panels, most notably scioAKI for early detection of acute kidney injury. With a focus on translating proteomic data into clinically actionable tools, Sciomics is positioning itself at the intersection of research services and in vitro diagnostic (IVD) development to enable precision medicine.

Therapeutic Areas